The Virtual Nodule Clinic software of Optellum is planned to be integrated with the AI solutions powered by GE’s Edison platform
Optellum joins forces with GE Healthcare for advancing precision diagnosis and treatment of lung cancer. (Credit: General Electric)
GE Healthcare has signed a letter of intent with Optellum, a UK-based provider of artificial intelligence (AI) decision support software, to partner on advancing precision diagnosis and treatment of lung cancer.
The medical imaging solutions provider alongside Optellum will aim to help providers address the challenge of determining the malignancy of a lung nodule, whether a suspicious lesion can be harmless or cancerous.
Optellum has developed an AI-powered clinical decision support software called Virtual Nodule Clinic. The software is designed to identify and score the probability of malignancy in a lung nodule, which is critical in judging if a biopsy is required, thereby speeding up diagnosis.
The lung health technology company is backed by the European Union’s EIT Health.
It had secured clearance from the US Food and Drug Administration (FDA) for the use of its Virtual Nodule Clinic software to support decision making in lung cancer diagnosis.
GE Healthcare is expected to work together with Optellum’s sales team for distributing the Virtual Nodule Clinic as well as to integrate it with AI solutions powered by its Edison platform.
Optellum founder and chief business officer Václav Potěšil said: “This collaboration is a major step forward for Optellum and the field of thoracic oncology at large.
“GE’s vast clinical network can accelerate deployment of Optellum’s platform and could enable a revolutionary redefinition of early lung cancer treatment for clinicians and patients around the world.”
Additionally, the parties plan to bring results from Optellum’s Lung Cancer Prediction AI into the existing workflow of various technological pathways of GE Healthcare, including computed tomography (CT) and picture archiving and communication systems (PACS).
GE Healthcare oncology solutions general manager Ben Newton said: “The precise diagnosis of lung cancer can greatly improve patient prognosis.
“The integration of imaging and medical device data from the Edison Platform with AI-enabled solutions like the one offered by the Optellum Virtual Nodule Clinic has the potential to streamline clinician workflows and advance our goal of making precision healthcare, taking the right action at the right time for every patient, at scale, as widely accessible as possible.”